tezosentan has been researched along with Hypertension, Portal in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bosch, J; Chiossi, E; Dingemanse, J; Dudley, FJ; Garcia-Pagan, JC; Jalan, R; Jessic, R; Kusic-Pajic, A; Lebrec, D; Mookerjee, RP; Moreau, R; Van Giersbergen, PL | 1 |
1 trial(s) available for tezosentan and Hypertension, Portal
| Article | Year |
|---|---|
Hemodynamics and pharmacokinetics of tezosentan, a dual endothelin receptor antagonist, in patients with cirrhosis.
Topics: Antihypertensive Agents; Double-Blind Method; Endothelin Receptor Antagonists; Endothelin-1; Female; Heart Rate; Hemodynamics; Humans; Hypertension, Portal; Infusions, Parenteral; Liver; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Male; Metabolic Clearance Rate; Middle Aged; Pyridines; Severity of Illness Index; Splanchnic Circulation; Tetrazoles; Vasodilator Agents | 2012 |